Global Molecular Diagnostics Cancer Market Growth (Status and Outlook) 2025-2031
According to this study, the global Molecular Diagnostics Cancer market size will reach US$ million by 2031.
A cancer molecular diagnosis is a laboratory test that examines certain genes, proteins, or other molecules in a sample of tissue, blood, or other body fluids.It also examines certain changes in genes or chromosomes that may cause or affect the chances of developing cancer.To help diagnose certain types of cancer.It can also be used to help plan treatment and find out treatment effects or prognosis.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the “Molecular Diagnostics Cancer Industry Forecast” looks at past sales and reviews total world Molecular Diagnostics Cancer sales in 2024, providing a comprehensive analysis by region and market sector of projected Molecular Diagnostics Cancer sales for 2025 through 2031. With Molecular Diagnostics Cancer sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Molecular Diagnostics Cancer industry.
This Insight Report provides a comprehensive analysis of the global Molecular Diagnostics Cancer landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Molecular Diagnostics Cancer portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Molecular Diagnostics Cancer market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Molecular Diagnostics Cancer and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Molecular Diagnostics Cancer.
This report presents a comprehensive overview, market shares, and growth opportunities of Molecular Diagnostics Cancer market by product type, application, key players and key regions and countries.
Segmentation by Type:
A cancer molecular diagnosis is a laboratory test that examines certain genes, proteins, or other molecules in a sample of tissue, blood, or other body fluids.It also examines certain changes in genes or chromosomes that may cause or affect the chances of developing cancer.To help diagnose certain types of cancer.It can also be used to help plan treatment and find out treatment effects or prognosis.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the “Molecular Diagnostics Cancer Industry Forecast” looks at past sales and reviews total world Molecular Diagnostics Cancer sales in 2024, providing a comprehensive analysis by region and market sector of projected Molecular Diagnostics Cancer sales for 2025 through 2031. With Molecular Diagnostics Cancer sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Molecular Diagnostics Cancer industry.
This Insight Report provides a comprehensive analysis of the global Molecular Diagnostics Cancer landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Molecular Diagnostics Cancer portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Molecular Diagnostics Cancer market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Molecular Diagnostics Cancer and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Molecular Diagnostics Cancer.
This report presents a comprehensive overview, market shares, and growth opportunities of Molecular Diagnostics Cancer market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Pharmacogenomic Diagnosis
- Liquid Biopsy
- Other
- Respiratory Cancer
- Cancer of Digestive System
- Cancer of Urinary System
- Cancer of Circulatory System
- Motor System Cancer
- Reproductive System Cancer
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Roche
- Danaher
- Siemens
- Abbott Laboratories
- ICON Plc
- AstraZeneca
- MDxHealth
- Invitae
- PlexBio
- Thermo Fisher Scientific
- Guardant Health
- Biocartis
- Bio-Techne
- Merck
- Foundation Medicine
- 10X Genomics
- Biodesix
- CytoTrack
- GenomOncology
- Luminex
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Molecular Diagnostics Cancer Market Size (2020-2031)
2.1.2 Molecular Diagnostics Cancer Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Molecular Diagnostics Cancer by Country/Region (2020, 2024 & 2031)
2.2 Molecular Diagnostics Cancer Segment by Type
2.2.1 Pharmacogenomic Diagnosis
2.2.2 Liquid Biopsy
2.2.3 Other
2.3 Molecular Diagnostics Cancer Market Size by Type
2.3.1 Molecular Diagnostics Cancer Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Molecular Diagnostics Cancer Market Size Market Share by Type (2020-2025)
2.4 Molecular Diagnostics Cancer Segment by Application
2.4.1 Respiratory Cancer
2.4.2 Cancer of Digestive System
2.4.3 Cancer of Urinary System
2.4.4 Cancer of Circulatory System
2.4.5 Motor System Cancer
2.4.6 Reproductive System Cancer
2.4.7 Other
2.5 Molecular Diagnostics Cancer Market Size by Application
2.5.1 Molecular Diagnostics Cancer Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Molecular Diagnostics Cancer Market Size Market Share by Application (2020-2025)
3 MOLECULAR DIAGNOSTICS CANCER MARKET SIZE BY PLAYER
3.1 Molecular Diagnostics Cancer Market Size Market Share by Player
3.1.1 Global Molecular Diagnostics Cancer Revenue by Player (2020-2025)
3.1.2 Global Molecular Diagnostics Cancer Revenue Market Share by Player (2020-2025)
3.2 Global Molecular Diagnostics Cancer Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 MOLECULAR DIAGNOSTICS CANCER BY REGION
4.1 Molecular Diagnostics Cancer Market Size by Region (2020-2025)
4.2 Global Molecular Diagnostics Cancer Annual Revenue by Country/Region (2020-2025)
4.3 Americas Molecular Diagnostics Cancer Market Size Growth (2020-2025)
4.4 APAC Molecular Diagnostics Cancer Market Size Growth (2020-2025)
4.5 Europe Molecular Diagnostics Cancer Market Size Growth (2020-2025)
4.6 Middle East & Africa Molecular Diagnostics Cancer Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Molecular Diagnostics Cancer Market Size by Country (2020-2025)
5.2 Americas Molecular Diagnostics Cancer Market Size by Type (2020-2025)
5.3 Americas Molecular Diagnostics Cancer Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Molecular Diagnostics Cancer Market Size by Region (2020-2025)
6.2 APAC Molecular Diagnostics Cancer Market Size by Type (2020-2025)
6.3 APAC Molecular Diagnostics Cancer Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Molecular Diagnostics Cancer Market Size by Country (2020-2025)
7.2 Europe Molecular Diagnostics Cancer Market Size by Type (2020-2025)
7.3 Europe Molecular Diagnostics Cancer Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Molecular Diagnostics Cancer by Region (2020-2025)
8.2 Middle East & Africa Molecular Diagnostics Cancer Market Size by Type (2020-2025)
8.3 Middle East & Africa Molecular Diagnostics Cancer Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL MOLECULAR DIAGNOSTICS CANCER MARKET FORECAST
10.1 Global Molecular Diagnostics Cancer Forecast by Region (2026-2031)
10.1.1 Global Molecular Diagnostics Cancer Forecast by Region (2026-2031)
10.1.2 Americas Molecular Diagnostics Cancer Forecast
10.1.3 APAC Molecular Diagnostics Cancer Forecast
10.1.4 Europe Molecular Diagnostics Cancer Forecast
10.1.5 Middle East & Africa Molecular Diagnostics Cancer Forecast
10.2 Americas Molecular Diagnostics Cancer Forecast by Country (2026-2031)
10.2.1 United States Market Molecular Diagnostics Cancer Forecast
10.2.2 Canada Market Molecular Diagnostics Cancer Forecast
10.2.3 Mexico Market Molecular Diagnostics Cancer Forecast
10.2.4 Brazil Market Molecular Diagnostics Cancer Forecast
10.3 APAC Molecular Diagnostics Cancer Forecast by Region (2026-2031)
10.3.1 China Molecular Diagnostics Cancer Market Forecast
10.3.2 Japan Market Molecular Diagnostics Cancer Forecast
10.3.3 Korea Market Molecular Diagnostics Cancer Forecast
10.3.4 Southeast Asia Market Molecular Diagnostics Cancer Forecast
10.3.5 India Market Molecular Diagnostics Cancer Forecast
10.3.6 Australia Market Molecular Diagnostics Cancer Forecast
10.4 Europe Molecular Diagnostics Cancer Forecast by Country (2026-2031)
10.4.1 Germany Market Molecular Diagnostics Cancer Forecast
10.4.2 France Market Molecular Diagnostics Cancer Forecast
10.4.3 UK Market Molecular Diagnostics Cancer Forecast
10.4.4 Italy Market Molecular Diagnostics Cancer Forecast
10.4.5 Russia Market Molecular Diagnostics Cancer Forecast
10.5 Middle East & Africa Molecular Diagnostics Cancer Forecast by Region (2026-2031)
10.5.1 Egypt Market Molecular Diagnostics Cancer Forecast
10.5.2 South Africa Market Molecular Diagnostics Cancer Forecast
10.5.3 Israel Market Molecular Diagnostics Cancer Forecast
10.5.4 Turkey Market Molecular Diagnostics Cancer Forecast
10.6 Global Molecular Diagnostics Cancer Forecast by Type (2026-2031)
10.7 Global Molecular Diagnostics Cancer Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Molecular Diagnostics Cancer Forecast
11 KEY PLAYERS ANALYSIS
11.1 Roche
11.1.1 Roche Company Information
11.1.2 Roche Molecular Diagnostics Cancer Product Offered
11.1.3 Roche Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Roche Main Business Overview
11.1.5 Roche Latest Developments
11.2 Danaher
11.2.1 Danaher Company Information
11.2.2 Danaher Molecular Diagnostics Cancer Product Offered
11.2.3 Danaher Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Danaher Main Business Overview
11.2.5 Danaher Latest Developments
11.3 Siemens
11.3.1 Siemens Company Information
11.3.2 Siemens Molecular Diagnostics Cancer Product Offered
11.3.3 Siemens Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Siemens Main Business Overview
11.3.5 Siemens Latest Developments
11.4 Abbott Laboratories
11.4.1 Abbott Laboratories Company Information
11.4.2 Abbott Laboratories Molecular Diagnostics Cancer Product Offered
11.4.3 Abbott Laboratories Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Abbott Laboratories Main Business Overview
11.4.5 Abbott Laboratories Latest Developments
11.5 ICON Plc
11.5.1 ICON Plc Company Information
11.5.2 ICON Plc Molecular Diagnostics Cancer Product Offered
11.5.3 ICON Plc Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 ICON Plc Main Business Overview
11.5.5 ICON Plc Latest Developments
11.6 AstraZeneca
11.6.1 AstraZeneca Company Information
11.6.2 AstraZeneca Molecular Diagnostics Cancer Product Offered
11.6.3 AstraZeneca Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 AstraZeneca Main Business Overview
11.6.5 AstraZeneca Latest Developments
11.7 MDxHealth
11.7.1 MDxHealth Company Information
11.7.2 MDxHealth Molecular Diagnostics Cancer Product Offered
11.7.3 MDxHealth Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 MDxHealth Main Business Overview
11.7.5 MDxHealth Latest Developments
11.8 Invitae
11.8.1 Invitae Company Information
11.8.2 Invitae Molecular Diagnostics Cancer Product Offered
11.8.3 Invitae Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Invitae Main Business Overview
11.8.5 Invitae Latest Developments
11.9 PlexBio
11.9.1 PlexBio Company Information
11.9.2 PlexBio Molecular Diagnostics Cancer Product Offered
11.9.3 PlexBio Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 PlexBio Main Business Overview
11.9.5 PlexBio Latest Developments
11.10 Thermo Fisher Scientific
11.10.1 Thermo Fisher Scientific Company Information
11.10.2 Thermo Fisher Scientific Molecular Diagnostics Cancer Product Offered
11.10.3 Thermo Fisher Scientific Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Thermo Fisher Scientific Main Business Overview
11.10.5 Thermo Fisher Scientific Latest Developments
11.11 Guardant Health
11.11.1 Guardant Health Company Information
11.11.2 Guardant Health Molecular Diagnostics Cancer Product Offered
11.11.3 Guardant Health Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Guardant Health Main Business Overview
11.11.5 Guardant Health Latest Developments
11.12 Biocartis
11.12.1 Biocartis Company Information
11.12.2 Biocartis Molecular Diagnostics Cancer Product Offered
11.12.3 Biocartis Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Biocartis Main Business Overview
11.12.5 Biocartis Latest Developments
11.13 Bio-Techne
11.13.1 Bio-Techne Company Information
11.13.2 Bio-Techne Molecular Diagnostics Cancer Product Offered
11.13.3 Bio-Techne Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Bio-Techne Main Business Overview
11.13.5 Bio-Techne Latest Developments
11.14 Merck
11.14.1 Merck Company Information
11.14.2 Merck Molecular Diagnostics Cancer Product Offered
11.14.3 Merck Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Merck Main Business Overview
11.14.5 Merck Latest Developments
11.15 Foundation Medicine
11.15.1 Foundation Medicine Company Information
11.15.2 Foundation Medicine Molecular Diagnostics Cancer Product Offered
11.15.3 Foundation Medicine Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Foundation Medicine Main Business Overview
11.15.5 Foundation Medicine Latest Developments
11.16 10X Genomics
11.16.1 10X Genomics Company Information
11.16.2 10X Genomics Molecular Diagnostics Cancer Product Offered
11.16.3 10X Genomics Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 10X Genomics Main Business Overview
11.16.5 10X Genomics Latest Developments
11.17 Biodesix
11.17.1 Biodesix Company Information
11.17.2 Biodesix Molecular Diagnostics Cancer Product Offered
11.17.3 Biodesix Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 Biodesix Main Business Overview
11.17.5 Biodesix Latest Developments
11.18 CytoTrack
11.18.1 CytoTrack Company Information
11.18.2 CytoTrack Molecular Diagnostics Cancer Product Offered
11.18.3 CytoTrack Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2020-2025)
11.18.4 CytoTrack Main Business Overview
11.18.5 CytoTrack Latest Developments
11.19 GenomOncology
11.19.1 GenomOncology Company Information
11.19.2 GenomOncology Molecular Diagnostics Cancer Product Offered
11.19.3 GenomOncology Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2020-2025)
11.19.4 GenomOncology Main Business Overview
11.19.5 GenomOncology Latest Developments
11.20 Luminex
11.20.1 Luminex Company Information
11.20.2 Luminex Molecular Diagnostics Cancer Product Offered
11.20.3 Luminex Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2020-2025)
11.20.4 Luminex Main Business Overview
11.20.5 Luminex Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Molecular Diagnostics Cancer Market Size (2020-2031)
2.1.2 Molecular Diagnostics Cancer Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Molecular Diagnostics Cancer by Country/Region (2020, 2024 & 2031)
2.2 Molecular Diagnostics Cancer Segment by Type
2.2.1 Pharmacogenomic Diagnosis
2.2.2 Liquid Biopsy
2.2.3 Other
2.3 Molecular Diagnostics Cancer Market Size by Type
2.3.1 Molecular Diagnostics Cancer Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Molecular Diagnostics Cancer Market Size Market Share by Type (2020-2025)
2.4 Molecular Diagnostics Cancer Segment by Application
2.4.1 Respiratory Cancer
2.4.2 Cancer of Digestive System
2.4.3 Cancer of Urinary System
2.4.4 Cancer of Circulatory System
2.4.5 Motor System Cancer
2.4.6 Reproductive System Cancer
2.4.7 Other
2.5 Molecular Diagnostics Cancer Market Size by Application
2.5.1 Molecular Diagnostics Cancer Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Molecular Diagnostics Cancer Market Size Market Share by Application (2020-2025)
3 MOLECULAR DIAGNOSTICS CANCER MARKET SIZE BY PLAYER
3.1 Molecular Diagnostics Cancer Market Size Market Share by Player
3.1.1 Global Molecular Diagnostics Cancer Revenue by Player (2020-2025)
3.1.2 Global Molecular Diagnostics Cancer Revenue Market Share by Player (2020-2025)
3.2 Global Molecular Diagnostics Cancer Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 MOLECULAR DIAGNOSTICS CANCER BY REGION
4.1 Molecular Diagnostics Cancer Market Size by Region (2020-2025)
4.2 Global Molecular Diagnostics Cancer Annual Revenue by Country/Region (2020-2025)
4.3 Americas Molecular Diagnostics Cancer Market Size Growth (2020-2025)
4.4 APAC Molecular Diagnostics Cancer Market Size Growth (2020-2025)
4.5 Europe Molecular Diagnostics Cancer Market Size Growth (2020-2025)
4.6 Middle East & Africa Molecular Diagnostics Cancer Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Molecular Diagnostics Cancer Market Size by Country (2020-2025)
5.2 Americas Molecular Diagnostics Cancer Market Size by Type (2020-2025)
5.3 Americas Molecular Diagnostics Cancer Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Molecular Diagnostics Cancer Market Size by Region (2020-2025)
6.2 APAC Molecular Diagnostics Cancer Market Size by Type (2020-2025)
6.3 APAC Molecular Diagnostics Cancer Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Molecular Diagnostics Cancer Market Size by Country (2020-2025)
7.2 Europe Molecular Diagnostics Cancer Market Size by Type (2020-2025)
7.3 Europe Molecular Diagnostics Cancer Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Molecular Diagnostics Cancer by Region (2020-2025)
8.2 Middle East & Africa Molecular Diagnostics Cancer Market Size by Type (2020-2025)
8.3 Middle East & Africa Molecular Diagnostics Cancer Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL MOLECULAR DIAGNOSTICS CANCER MARKET FORECAST
10.1 Global Molecular Diagnostics Cancer Forecast by Region (2026-2031)
10.1.1 Global Molecular Diagnostics Cancer Forecast by Region (2026-2031)
10.1.2 Americas Molecular Diagnostics Cancer Forecast
10.1.3 APAC Molecular Diagnostics Cancer Forecast
10.1.4 Europe Molecular Diagnostics Cancer Forecast
10.1.5 Middle East & Africa Molecular Diagnostics Cancer Forecast
10.2 Americas Molecular Diagnostics Cancer Forecast by Country (2026-2031)
10.2.1 United States Market Molecular Diagnostics Cancer Forecast
10.2.2 Canada Market Molecular Diagnostics Cancer Forecast
10.2.3 Mexico Market Molecular Diagnostics Cancer Forecast
10.2.4 Brazil Market Molecular Diagnostics Cancer Forecast
10.3 APAC Molecular Diagnostics Cancer Forecast by Region (2026-2031)
10.3.1 China Molecular Diagnostics Cancer Market Forecast
10.3.2 Japan Market Molecular Diagnostics Cancer Forecast
10.3.3 Korea Market Molecular Diagnostics Cancer Forecast
10.3.4 Southeast Asia Market Molecular Diagnostics Cancer Forecast
10.3.5 India Market Molecular Diagnostics Cancer Forecast
10.3.6 Australia Market Molecular Diagnostics Cancer Forecast
10.4 Europe Molecular Diagnostics Cancer Forecast by Country (2026-2031)
10.4.1 Germany Market Molecular Diagnostics Cancer Forecast
10.4.2 France Market Molecular Diagnostics Cancer Forecast
10.4.3 UK Market Molecular Diagnostics Cancer Forecast
10.4.4 Italy Market Molecular Diagnostics Cancer Forecast
10.4.5 Russia Market Molecular Diagnostics Cancer Forecast
10.5 Middle East & Africa Molecular Diagnostics Cancer Forecast by Region (2026-2031)
10.5.1 Egypt Market Molecular Diagnostics Cancer Forecast
10.5.2 South Africa Market Molecular Diagnostics Cancer Forecast
10.5.3 Israel Market Molecular Diagnostics Cancer Forecast
10.5.4 Turkey Market Molecular Diagnostics Cancer Forecast
10.6 Global Molecular Diagnostics Cancer Forecast by Type (2026-2031)
10.7 Global Molecular Diagnostics Cancer Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Molecular Diagnostics Cancer Forecast
11 KEY PLAYERS ANALYSIS
11.1 Roche
11.1.1 Roche Company Information
11.1.2 Roche Molecular Diagnostics Cancer Product Offered
11.1.3 Roche Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Roche Main Business Overview
11.1.5 Roche Latest Developments
11.2 Danaher
11.2.1 Danaher Company Information
11.2.2 Danaher Molecular Diagnostics Cancer Product Offered
11.2.3 Danaher Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Danaher Main Business Overview
11.2.5 Danaher Latest Developments
11.3 Siemens
11.3.1 Siemens Company Information
11.3.2 Siemens Molecular Diagnostics Cancer Product Offered
11.3.3 Siemens Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Siemens Main Business Overview
11.3.5 Siemens Latest Developments
11.4 Abbott Laboratories
11.4.1 Abbott Laboratories Company Information
11.4.2 Abbott Laboratories Molecular Diagnostics Cancer Product Offered
11.4.3 Abbott Laboratories Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Abbott Laboratories Main Business Overview
11.4.5 Abbott Laboratories Latest Developments
11.5 ICON Plc
11.5.1 ICON Plc Company Information
11.5.2 ICON Plc Molecular Diagnostics Cancer Product Offered
11.5.3 ICON Plc Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 ICON Plc Main Business Overview
11.5.5 ICON Plc Latest Developments
11.6 AstraZeneca
11.6.1 AstraZeneca Company Information
11.6.2 AstraZeneca Molecular Diagnostics Cancer Product Offered
11.6.3 AstraZeneca Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 AstraZeneca Main Business Overview
11.6.5 AstraZeneca Latest Developments
11.7 MDxHealth
11.7.1 MDxHealth Company Information
11.7.2 MDxHealth Molecular Diagnostics Cancer Product Offered
11.7.3 MDxHealth Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 MDxHealth Main Business Overview
11.7.5 MDxHealth Latest Developments
11.8 Invitae
11.8.1 Invitae Company Information
11.8.2 Invitae Molecular Diagnostics Cancer Product Offered
11.8.3 Invitae Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Invitae Main Business Overview
11.8.5 Invitae Latest Developments
11.9 PlexBio
11.9.1 PlexBio Company Information
11.9.2 PlexBio Molecular Diagnostics Cancer Product Offered
11.9.3 PlexBio Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 PlexBio Main Business Overview
11.9.5 PlexBio Latest Developments
11.10 Thermo Fisher Scientific
11.10.1 Thermo Fisher Scientific Company Information
11.10.2 Thermo Fisher Scientific Molecular Diagnostics Cancer Product Offered
11.10.3 Thermo Fisher Scientific Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Thermo Fisher Scientific Main Business Overview
11.10.5 Thermo Fisher Scientific Latest Developments
11.11 Guardant Health
11.11.1 Guardant Health Company Information
11.11.2 Guardant Health Molecular Diagnostics Cancer Product Offered
11.11.3 Guardant Health Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Guardant Health Main Business Overview
11.11.5 Guardant Health Latest Developments
11.12 Biocartis
11.12.1 Biocartis Company Information
11.12.2 Biocartis Molecular Diagnostics Cancer Product Offered
11.12.3 Biocartis Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Biocartis Main Business Overview
11.12.5 Biocartis Latest Developments
11.13 Bio-Techne
11.13.1 Bio-Techne Company Information
11.13.2 Bio-Techne Molecular Diagnostics Cancer Product Offered
11.13.3 Bio-Techne Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Bio-Techne Main Business Overview
11.13.5 Bio-Techne Latest Developments
11.14 Merck
11.14.1 Merck Company Information
11.14.2 Merck Molecular Diagnostics Cancer Product Offered
11.14.3 Merck Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Merck Main Business Overview
11.14.5 Merck Latest Developments
11.15 Foundation Medicine
11.15.1 Foundation Medicine Company Information
11.15.2 Foundation Medicine Molecular Diagnostics Cancer Product Offered
11.15.3 Foundation Medicine Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Foundation Medicine Main Business Overview
11.15.5 Foundation Medicine Latest Developments
11.16 10X Genomics
11.16.1 10X Genomics Company Information
11.16.2 10X Genomics Molecular Diagnostics Cancer Product Offered
11.16.3 10X Genomics Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 10X Genomics Main Business Overview
11.16.5 10X Genomics Latest Developments
11.17 Biodesix
11.17.1 Biodesix Company Information
11.17.2 Biodesix Molecular Diagnostics Cancer Product Offered
11.17.3 Biodesix Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 Biodesix Main Business Overview
11.17.5 Biodesix Latest Developments
11.18 CytoTrack
11.18.1 CytoTrack Company Information
11.18.2 CytoTrack Molecular Diagnostics Cancer Product Offered
11.18.3 CytoTrack Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2020-2025)
11.18.4 CytoTrack Main Business Overview
11.18.5 CytoTrack Latest Developments
11.19 GenomOncology
11.19.1 GenomOncology Company Information
11.19.2 GenomOncology Molecular Diagnostics Cancer Product Offered
11.19.3 GenomOncology Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2020-2025)
11.19.4 GenomOncology Main Business Overview
11.19.5 GenomOncology Latest Developments
11.20 Luminex
11.20.1 Luminex Company Information
11.20.2 Luminex Molecular Diagnostics Cancer Product Offered
11.20.3 Luminex Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2020-2025)
11.20.4 Luminex Main Business Overview
11.20.5 Luminex Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Molecular Diagnostics Cancer Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Molecular Diagnostics Cancer Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Pharmacogenomic Diagnosis
Table 4. Major Players of Liquid Biopsy
Table 5. Major Players of Other
Table 6. Molecular Diagnostics Cancer Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 7. Global Molecular Diagnostics Cancer Market Size by Type (2020-2025) & ($ millions)
Table 8. Global Molecular Diagnostics Cancer Market Size Market Share by Type (2020-2025)
Table 9. Molecular Diagnostics Cancer Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Molecular Diagnostics Cancer Market Size by Application (2020-2025) & ($ millions)
Table 11. Global Molecular Diagnostics Cancer Market Size Market Share by Application (2020-2025)
Table 12. Global Molecular Diagnostics Cancer Revenue by Player (2020-2025) & ($ millions)
Table 13. Global Molecular Diagnostics Cancer Revenue Market Share by Player (2020-2025)
Table 14. Molecular Diagnostics Cancer Key Players Head office and Products Offered
Table 15. Molecular Diagnostics Cancer Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Molecular Diagnostics Cancer Market Size by Region (2020-2025) & ($ millions)
Table 19. Global Molecular Diagnostics Cancer Market Size Market Share by Region (2020-2025)
Table 20. Global Molecular Diagnostics Cancer Revenue by Country/Region (2020-2025) & ($ millions)
Table 21. Global Molecular Diagnostics Cancer Revenue Market Share by Country/Region (2020-2025)
Table 22. Americas Molecular Diagnostics Cancer Market Size by Country (2020-2025) & ($ millions)
Table 23. Americas Molecular Diagnostics Cancer Market Size Market Share by Country (2020-2025)
Table 24. Americas Molecular Diagnostics Cancer Market Size by Type (2020-2025) & ($ millions)
Table 25. Americas Molecular Diagnostics Cancer Market Size Market Share by Type (2020-2025)
Table 26. Americas Molecular Diagnostics Cancer Market Size by Application (2020-2025) & ($ millions)
Table 27. Americas Molecular Diagnostics Cancer Market Size Market Share by Application (2020-2025)
Table 28. APAC Molecular Diagnostics Cancer Market Size by Region (2020-2025) & ($ millions)
Table 29. APAC Molecular Diagnostics Cancer Market Size Market Share by Region (2020-2025)
Table 30. APAC Molecular Diagnostics Cancer Market Size by Type (2020-2025) & ($ millions)
Table 31. APAC Molecular Diagnostics Cancer Market Size by Application (2020-2025) & ($ millions)
Table 32. Europe Molecular Diagnostics Cancer Market Size by Country (2020-2025) & ($ millions)
Table 33. Europe Molecular Diagnostics Cancer Market Size Market Share by Country (2020-2025)
Table 34. Europe Molecular Diagnostics Cancer Market Size by Type (2020-2025) & ($ millions)
Table 35. Europe Molecular Diagnostics Cancer Market Size by Application (2020-2025) & ($ millions)
Table 36. Middle East & Africa Molecular Diagnostics Cancer Market Size by Region (2020-2025) & ($ millions)
Table 37. Middle East & Africa Molecular Diagnostics Cancer Market Size by Type (2020-2025) & ($ millions)
Table 38. Middle East & Africa Molecular Diagnostics Cancer Market Size by Application (2020-2025) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Molecular Diagnostics Cancer
Table 40. Key Market Challenges & Risks of Molecular Diagnostics Cancer
Table 41. Key Industry Trends of Molecular Diagnostics Cancer
Table 42. Global Molecular Diagnostics Cancer Market Size Forecast by Region (2026-2031) & ($ millions)
Table 43. Global Molecular Diagnostics Cancer Market Size Market Share Forecast by Region (2026-2031)
Table 44. Global Molecular Diagnostics Cancer Market Size Forecast by Type (2026-2031) & ($ millions)
Table 45. Global Molecular Diagnostics Cancer Market Size Forecast by Application (2026-2031) & ($ millions)
Table 46. Roche Details, Company Type, Molecular Diagnostics Cancer Area Served and Its Competitors
Table 47. Roche Molecular Diagnostics Cancer Product Offered
Table 48. Roche Molecular Diagnostics Cancer Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 49. Roche Main Business
Table 50. Roche Latest Developments
Table 51. Danaher Details, Company Type, Molecular Diagnostics Cancer Area Served and Its Competitors
Table 52. Danaher Molecular Diagnostics Cancer Product Offered
Table 53. Danaher Molecular Diagnostics Cancer Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. Danaher Main Business
Table 55. Danaher Latest Developments
Table 56. Siemens Details, Company Type, Molecular Diagnostics Cancer Area Served and Its Competitors
Table 57. Siemens Molecular Diagnostics Cancer Product Offered
Table 58. Siemens Molecular Diagnostics Cancer Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. Siemens Main Business
Table 60. Siemens Latest Developments
Table 61. Abbott Laboratories Details, Company Type, Molecular Diagnostics Cancer Area Served and Its Competitors
Table 62. Abbott Laboratories Molecular Diagnostics Cancer Product Offered
Table 63. Abbott Laboratories Molecular Diagnostics Cancer Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. Abbott Laboratories Main Business
Table 65. Abbott Laboratories Latest Developments
Table 66. ICON Plc Details, Company Type, Molecular Diagnostics Cancer Area Served and Its Competitors
Table 67. ICON Plc Molecular Diagnostics Cancer Product Offered
Table 68. ICON Plc Molecular Diagnostics Cancer Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 69. ICON Plc Main Business
Table 70. ICON Plc Latest Developments
Table 71. AstraZeneca Details, Company Type, Molecular Diagnostics Cancer Area Served and Its Competitors
Table 72. AstraZeneca Molecular Diagnostics Cancer Product Offered
Table 73. AstraZeneca Molecular Diagnostics Cancer Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 74. AstraZeneca Main Business
Table 75. AstraZeneca Latest Developments
Table 76. MDxHealth Details, Company Type, Molecular Diagnostics Cancer Area Served and Its Competitors
Table 77. MDxHealth Molecular Diagnostics Cancer Product Offered
Table 78. MDxHealth Molecular Diagnostics Cancer Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 79. MDxHealth Main Business
Table 80. MDxHealth Latest Developments
Table 81. Invitae Details, Company Type, Molecular Diagnostics Cancer Area Served and Its Competitors
Table 82. Invitae Molecular Diagnostics Cancer Product Offered
Table 83. Invitae Molecular Diagnostics Cancer Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 84. Invitae Main Business
Table 85. Invitae Latest Developments
Table 86. PlexBio Details, Company Type, Molecular Diagnostics Cancer Area Served and Its Competitors
Table 87. PlexBio Molecular Diagnostics Cancer Product Offered
Table 88. PlexBio Molecular Diagnostics Cancer Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 89. PlexBio Main Business
Table 90. PlexBio Latest Developments
Table 91. Thermo Fisher Scientific Details, Company Type, Molecular Diagnostics Cancer Area Served and Its Competitors
Table 92. Thermo Fisher Scientific Molecular Diagnostics Cancer Product Offered
Table 93. Thermo Fisher Scientific Molecular Diagnostics Cancer Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 94. Thermo Fisher Scientific Main Business
Table 95. Thermo Fisher Scientific Latest Developments
Table 96. Guardant Health Details, Company Type, Molecular Diagnostics Cancer Area Served and Its Competitors
Table 97. Guardant Health Molecular Diagnostics Cancer Product Offered
Table 98. Guardant Health Molecular Diagnostics Cancer Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 99. Guardant Health Main Business
Table 100. Guardant Health Latest Developments
Table 101. Biocartis Details, Company Type, Molecular Diagnostics Cancer Area Served and Its Competitors
Table 102. Biocartis Molecular Diagnostics Cancer Product Offered
Table 103. Biocartis Molecular Diagnostics Cancer Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 104. Biocartis Main Business
Table 105. Biocartis Latest Developments
Table 106. Bio-Techne Details, Company Type, Molecular Diagnostics Cancer Area Served and Its Competitors
Table 107. Bio-Techne Molecular Diagnostics Cancer Product Offered
Table 108. Bio-Techne Molecular Diagnostics Cancer Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 109. Bio-Techne Main Business
Table 110. Bio-Techne Latest Developments
Table 111. Merck Details, Company Type, Molecular Diagnostics Cancer Area Served and Its Competitors
Table 112. Merck Molecular Diagnostics Cancer Product Offered
Table 113. Merck Molecular Diagnostics Cancer Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 114. Merck Main Business
Table 115. Merck Latest Developments
Table 116. Foundation Medicine Details, Company Type, Molecular Diagnostics Cancer Area Served and Its Competitors
Table 117. Foundation Medicine Molecular Diagnostics Cancer Product Offered
Table 118. Foundation Medicine Molecular Diagnostics Cancer Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 119. Foundation Medicine Main Business
Table 120. Foundation Medicine Latest Developments
Table 121. 10X Genomics Details, Company Type, Molecular Diagnostics Cancer Area Served and Its Competitors
Table 122. 10X Genomics Molecular Diagnostics Cancer Product Offered
Table 123. 10X Genomics Molecular Diagnostics Cancer Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 124. 10X Genomics Main Business
Table 125. 10X Genomics Latest Developments
Table 126. Biodesix Details, Company Type, Molecular Diagnostics Cancer Area Served and Its Competitors
Table 127. Biodesix Molecular Diagnostics Cancer Product Offered
Table 128. Biodesix Molecular Diagnostics Cancer Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 129. Biodesix Main Business
Table 130. Biodesix Latest Developments
Table 131. CytoTrack Details, Company Type, Molecular Diagnostics Cancer Area Served and Its Competitors
Table 132. CytoTrack Molecular Diagnostics Cancer Product Offered
Table 133. CytoTrack Molecular Diagnostics Cancer Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 134. CytoTrack Main Business
Table 135. CytoTrack Latest Developments
Table 136. GenomOncology Details, Company Type, Molecular Diagnostics Cancer Area Served and Its Competitors
Table 137. GenomOncology Molecular Diagnostics Cancer Product Offered
Table 138. GenomOncology Molecular Diagnostics Cancer Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 139. GenomOncology Main Business
Table 140. GenomOncology Latest Developments
Table 141. Luminex Details, Company Type, Molecular Diagnostics Cancer Area Served and Its Competitors
Table 142. Luminex Molecular Diagnostics Cancer Product Offered
Table 143. Luminex Molecular Diagnostics Cancer Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 144. Luminex Main Business
Table 145. Luminex Latest Developments
Table 1. Molecular Diagnostics Cancer Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Molecular Diagnostics Cancer Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Pharmacogenomic Diagnosis
Table 4. Major Players of Liquid Biopsy
Table 5. Major Players of Other
Table 6. Molecular Diagnostics Cancer Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 7. Global Molecular Diagnostics Cancer Market Size by Type (2020-2025) & ($ millions)
Table 8. Global Molecular Diagnostics Cancer Market Size Market Share by Type (2020-2025)
Table 9. Molecular Diagnostics Cancer Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Molecular Diagnostics Cancer Market Size by Application (2020-2025) & ($ millions)
Table 11. Global Molecular Diagnostics Cancer Market Size Market Share by Application (2020-2025)
Table 12. Global Molecular Diagnostics Cancer Revenue by Player (2020-2025) & ($ millions)
Table 13. Global Molecular Diagnostics Cancer Revenue Market Share by Player (2020-2025)
Table 14. Molecular Diagnostics Cancer Key Players Head office and Products Offered
Table 15. Molecular Diagnostics Cancer Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Molecular Diagnostics Cancer Market Size by Region (2020-2025) & ($ millions)
Table 19. Global Molecular Diagnostics Cancer Market Size Market Share by Region (2020-2025)
Table 20. Global Molecular Diagnostics Cancer Revenue by Country/Region (2020-2025) & ($ millions)
Table 21. Global Molecular Diagnostics Cancer Revenue Market Share by Country/Region (2020-2025)
Table 22. Americas Molecular Diagnostics Cancer Market Size by Country (2020-2025) & ($ millions)
Table 23. Americas Molecular Diagnostics Cancer Market Size Market Share by Country (2020-2025)
Table 24. Americas Molecular Diagnostics Cancer Market Size by Type (2020-2025) & ($ millions)
Table 25. Americas Molecular Diagnostics Cancer Market Size Market Share by Type (2020-2025)
Table 26. Americas Molecular Diagnostics Cancer Market Size by Application (2020-2025) & ($ millions)
Table 27. Americas Molecular Diagnostics Cancer Market Size Market Share by Application (2020-2025)
Table 28. APAC Molecular Diagnostics Cancer Market Size by Region (2020-2025) & ($ millions)
Table 29. APAC Molecular Diagnostics Cancer Market Size Market Share by Region (2020-2025)
Table 30. APAC Molecular Diagnostics Cancer Market Size by Type (2020-2025) & ($ millions)
Table 31. APAC Molecular Diagnostics Cancer Market Size by Application (2020-2025) & ($ millions)
Table 32. Europe Molecular Diagnostics Cancer Market Size by Country (2020-2025) & ($ millions)
Table 33. Europe Molecular Diagnostics Cancer Market Size Market Share by Country (2020-2025)
Table 34. Europe Molecular Diagnostics Cancer Market Size by Type (2020-2025) & ($ millions)
Table 35. Europe Molecular Diagnostics Cancer Market Size by Application (2020-2025) & ($ millions)
Table 36. Middle East & Africa Molecular Diagnostics Cancer Market Size by Region (2020-2025) & ($ millions)
Table 37. Middle East & Africa Molecular Diagnostics Cancer Market Size by Type (2020-2025) & ($ millions)
Table 38. Middle East & Africa Molecular Diagnostics Cancer Market Size by Application (2020-2025) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Molecular Diagnostics Cancer
Table 40. Key Market Challenges & Risks of Molecular Diagnostics Cancer
Table 41. Key Industry Trends of Molecular Diagnostics Cancer
Table 42. Global Molecular Diagnostics Cancer Market Size Forecast by Region (2026-2031) & ($ millions)
Table 43. Global Molecular Diagnostics Cancer Market Size Market Share Forecast by Region (2026-2031)
Table 44. Global Molecular Diagnostics Cancer Market Size Forecast by Type (2026-2031) & ($ millions)
Table 45. Global Molecular Diagnostics Cancer Market Size Forecast by Application (2026-2031) & ($ millions)
Table 46. Roche Details, Company Type, Molecular Diagnostics Cancer Area Served and Its Competitors
Table 47. Roche Molecular Diagnostics Cancer Product Offered
Table 48. Roche Molecular Diagnostics Cancer Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 49. Roche Main Business
Table 50. Roche Latest Developments
Table 51. Danaher Details, Company Type, Molecular Diagnostics Cancer Area Served and Its Competitors
Table 52. Danaher Molecular Diagnostics Cancer Product Offered
Table 53. Danaher Molecular Diagnostics Cancer Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. Danaher Main Business
Table 55. Danaher Latest Developments
Table 56. Siemens Details, Company Type, Molecular Diagnostics Cancer Area Served and Its Competitors
Table 57. Siemens Molecular Diagnostics Cancer Product Offered
Table 58. Siemens Molecular Diagnostics Cancer Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. Siemens Main Business
Table 60. Siemens Latest Developments
Table 61. Abbott Laboratories Details, Company Type, Molecular Diagnostics Cancer Area Served and Its Competitors
Table 62. Abbott Laboratories Molecular Diagnostics Cancer Product Offered
Table 63. Abbott Laboratories Molecular Diagnostics Cancer Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. Abbott Laboratories Main Business
Table 65. Abbott Laboratories Latest Developments
Table 66. ICON Plc Details, Company Type, Molecular Diagnostics Cancer Area Served and Its Competitors
Table 67. ICON Plc Molecular Diagnostics Cancer Product Offered
Table 68. ICON Plc Molecular Diagnostics Cancer Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 69. ICON Plc Main Business
Table 70. ICON Plc Latest Developments
Table 71. AstraZeneca Details, Company Type, Molecular Diagnostics Cancer Area Served and Its Competitors
Table 72. AstraZeneca Molecular Diagnostics Cancer Product Offered
Table 73. AstraZeneca Molecular Diagnostics Cancer Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 74. AstraZeneca Main Business
Table 75. AstraZeneca Latest Developments
Table 76. MDxHealth Details, Company Type, Molecular Diagnostics Cancer Area Served and Its Competitors
Table 77. MDxHealth Molecular Diagnostics Cancer Product Offered
Table 78. MDxHealth Molecular Diagnostics Cancer Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 79. MDxHealth Main Business
Table 80. MDxHealth Latest Developments
Table 81. Invitae Details, Company Type, Molecular Diagnostics Cancer Area Served and Its Competitors
Table 82. Invitae Molecular Diagnostics Cancer Product Offered
Table 83. Invitae Molecular Diagnostics Cancer Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 84. Invitae Main Business
Table 85. Invitae Latest Developments
Table 86. PlexBio Details, Company Type, Molecular Diagnostics Cancer Area Served and Its Competitors
Table 87. PlexBio Molecular Diagnostics Cancer Product Offered
Table 88. PlexBio Molecular Diagnostics Cancer Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 89. PlexBio Main Business
Table 90. PlexBio Latest Developments
Table 91. Thermo Fisher Scientific Details, Company Type, Molecular Diagnostics Cancer Area Served and Its Competitors
Table 92. Thermo Fisher Scientific Molecular Diagnostics Cancer Product Offered
Table 93. Thermo Fisher Scientific Molecular Diagnostics Cancer Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 94. Thermo Fisher Scientific Main Business
Table 95. Thermo Fisher Scientific Latest Developments
Table 96. Guardant Health Details, Company Type, Molecular Diagnostics Cancer Area Served and Its Competitors
Table 97. Guardant Health Molecular Diagnostics Cancer Product Offered
Table 98. Guardant Health Molecular Diagnostics Cancer Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 99. Guardant Health Main Business
Table 100. Guardant Health Latest Developments
Table 101. Biocartis Details, Company Type, Molecular Diagnostics Cancer Area Served and Its Competitors
Table 102. Biocartis Molecular Diagnostics Cancer Product Offered
Table 103. Biocartis Molecular Diagnostics Cancer Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 104. Biocartis Main Business
Table 105. Biocartis Latest Developments
Table 106. Bio-Techne Details, Company Type, Molecular Diagnostics Cancer Area Served and Its Competitors
Table 107. Bio-Techne Molecular Diagnostics Cancer Product Offered
Table 108. Bio-Techne Molecular Diagnostics Cancer Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 109. Bio-Techne Main Business
Table 110. Bio-Techne Latest Developments
Table 111. Merck Details, Company Type, Molecular Diagnostics Cancer Area Served and Its Competitors
Table 112. Merck Molecular Diagnostics Cancer Product Offered
Table 113. Merck Molecular Diagnostics Cancer Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 114. Merck Main Business
Table 115. Merck Latest Developments
Table 116. Foundation Medicine Details, Company Type, Molecular Diagnostics Cancer Area Served and Its Competitors
Table 117. Foundation Medicine Molecular Diagnostics Cancer Product Offered
Table 118. Foundation Medicine Molecular Diagnostics Cancer Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 119. Foundation Medicine Main Business
Table 120. Foundation Medicine Latest Developments
Table 121. 10X Genomics Details, Company Type, Molecular Diagnostics Cancer Area Served and Its Competitors
Table 122. 10X Genomics Molecular Diagnostics Cancer Product Offered
Table 123. 10X Genomics Molecular Diagnostics Cancer Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 124. 10X Genomics Main Business
Table 125. 10X Genomics Latest Developments
Table 126. Biodesix Details, Company Type, Molecular Diagnostics Cancer Area Served and Its Competitors
Table 127. Biodesix Molecular Diagnostics Cancer Product Offered
Table 128. Biodesix Molecular Diagnostics Cancer Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 129. Biodesix Main Business
Table 130. Biodesix Latest Developments
Table 131. CytoTrack Details, Company Type, Molecular Diagnostics Cancer Area Served and Its Competitors
Table 132. CytoTrack Molecular Diagnostics Cancer Product Offered
Table 133. CytoTrack Molecular Diagnostics Cancer Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 134. CytoTrack Main Business
Table 135. CytoTrack Latest Developments
Table 136. GenomOncology Details, Company Type, Molecular Diagnostics Cancer Area Served and Its Competitors
Table 137. GenomOncology Molecular Diagnostics Cancer Product Offered
Table 138. GenomOncology Molecular Diagnostics Cancer Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 139. GenomOncology Main Business
Table 140. GenomOncology Latest Developments
Table 141. Luminex Details, Company Type, Molecular Diagnostics Cancer Area Served and Its Competitors
Table 142. Luminex Molecular Diagnostics Cancer Product Offered
Table 143. Luminex Molecular Diagnostics Cancer Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 144. Luminex Main Business
Table 145. Luminex Latest Developments
LIST OF FIGURES
Figure 1. Molecular Diagnostics Cancer Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Molecular Diagnostics Cancer Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Molecular Diagnostics Cancer Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Molecular Diagnostics Cancer Sales Market Share by Country/Region (2024)
Figure 8. Molecular Diagnostics Cancer Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Molecular Diagnostics Cancer Market Size Market Share by Type in 2024
Figure 10. Molecular Diagnostics Cancer in Respiratory Cancer
Figure 11. Global Molecular Diagnostics Cancer Market: Respiratory Cancer (2020-2025) & ($ millions)
Figure 12. Molecular Diagnostics Cancer in Cancer of Digestive System
Figure 13. Global Molecular Diagnostics Cancer Market: Cancer of Digestive System (2020-2025) & ($ millions)
Figure 14. Molecular Diagnostics Cancer in Cancer of Urinary System
Figure 15. Global Molecular Diagnostics Cancer Market: Cancer of Urinary System (2020-2025) & ($ millions)
Figure 16. Molecular Diagnostics Cancer in Cancer of Circulatory System
Figure 17. Global Molecular Diagnostics Cancer Market: Cancer of Circulatory System (2020-2025) & ($ millions)
Figure 18. Molecular Diagnostics Cancer in Motor System Cancer
Figure 19. Global Molecular Diagnostics Cancer Market: Motor System Cancer (2020-2025) & ($ millions)
Figure 20. Molecular Diagnostics Cancer in Reproductive System Cancer
Figure 21. Global Molecular Diagnostics Cancer Market: Reproductive System Cancer (2020-2025) & ($ millions)
Figure 22. Molecular Diagnostics Cancer in Other
Figure 23. Global Molecular Diagnostics Cancer Market: Other (2020-2025) & ($ millions)
Figure 24. Global Molecular Diagnostics Cancer Market Size Market Share by Application in 2024
Figure 25. Global Molecular Diagnostics Cancer Revenue Market Share by Player in 2024
Figure 26. Global Molecular Diagnostics Cancer Market Size Market Share by Region (2020-2025)
Figure 27. Americas Molecular Diagnostics Cancer Market Size 2020-2025 ($ millions)
Figure 28. APAC Molecular Diagnostics Cancer Market Size 2020-2025 ($ millions)
Figure 29. Europe Molecular Diagnostics Cancer Market Size 2020-2025 ($ millions)
Figure 30. Middle East & Africa Molecular Diagnostics Cancer Market Size 2020-2025 ($ millions)
Figure 31. Americas Molecular Diagnostics Cancer Value Market Share by Country in 2024
Figure 32. United States Molecular Diagnostics Cancer Market Size Growth 2020-2025 ($ millions)
Figure 33. Canada Molecular Diagnostics Cancer Market Size Growth 2020-2025 ($ millions)
Figure 34. Mexico Molecular Diagnostics Cancer Market Size Growth 2020-2025 ($ millions)
Figure 35. Brazil Molecular Diagnostics Cancer Market Size Growth 2020-2025 ($ millions)
Figure 36. APAC Molecular Diagnostics Cancer Market Size Market Share by Region in 2024
Figure 37. APAC Molecular Diagnostics Cancer Market Size Market Share by Type (2020-2025)
Figure 38. APAC Molecular Diagnostics Cancer Market Size Market Share by Application (2020-2025)
Figure 39. China Molecular Diagnostics Cancer Market Size Growth 2020-2025 ($ millions)
Figure 40. Japan Molecular Diagnostics Cancer Market Size Growth 2020-2025 ($ millions)
Figure 41. South Korea Molecular Diagnostics Cancer Market Size Growth 2020-2025 ($ millions)
Figure 42. Southeast Asia Molecular Diagnostics Cancer Market Size Growth 2020-2025 ($ millions)
Figure 43. India Molecular Diagnostics Cancer Market Size Growth 2020-2025 ($ millions)
Figure 44. Australia Molecular Diagnostics Cancer Market Size Growth 2020-2025 ($ millions)
Figure 45. Europe Molecular Diagnostics Cancer Market Size Market Share by Country in 2024
Figure 46. Europe Molecular Diagnostics Cancer Market Size Market Share by Type (2020-2025)
Figure 47. Europe Molecular Diagnostics Cancer Market Size Market Share by Application (2020-2025)
Figure 48. Germany Molecular Diagnostics Cancer Market Size Growth 2020-2025 ($ millions)
Figure 49. France Molecular Diagnostics Cancer Market Size Growth 2020-2025 ($ millions)
Figure 50. UK Molecular Diagnostics Cancer Market Size Growth 2020-2025 ($ millions)
Figure 51. Italy Molecular Diagnostics Cancer Market Size Growth 2020-2025 ($ millions)
Figure 52. Russia Molecular Diagnostics Cancer Market Size Growth 2020-2025 ($ millions)
Figure 53. Middle East & Africa Molecular Diagnostics Cancer Market Size Market Share by Region (2020-2025)
Figure 54. Middle East & Africa Molecular Diagnostics Cancer Market Size Market Share by Type (2020-2025)
Figure 55. Middle East & Africa Molecular Diagnostics Cancer Market Size Market Share by Application (2020-2025)
Figure 56. Egypt Molecular Diagnostics Cancer Market Size Growth 2020-2025 ($ millions)
Figure 57. South Africa Molecular Diagnostics Cancer Market Size Growth 2020-2025 ($ millions)
Figure 58. Israel Molecular Diagnostics Cancer Market Size Growth 2020-2025 ($ millions)
Figure 59. Turkey Molecular Diagnostics Cancer Market Size Growth 2020-2025 ($ millions)
Figure 60. GCC Countries Molecular Diagnostics Cancer Market Size Growth 2020-2025 ($ millions)
Figure 61. Americas Molecular Diagnostics Cancer Market Size 2026-2031 ($ millions)
Figure 62. APAC Molecular Diagnostics Cancer Market Size 2026-2031 ($ millions)
Figure 63. Europe Molecular Diagnostics Cancer Market Size 2026-2031 ($ millions)
Figure 64. Middle East & Africa Molecular Diagnostics Cancer Market Size 2026-2031 ($ millions)
Figure 65. United States Molecular Diagnostics Cancer Market Size 2026-2031 ($ millions)
Figure 66. Canada Molecular Diagnostics Cancer Market Size 2026-2031 ($ millions)
Figure 67. Mexico Molecular Diagnostics Cancer Market Size 2026-2031 ($ millions)
Figure 68. Brazil Molecular Diagnostics Cancer Market Size 2026-2031 ($ millions)
Figure 69. China Molecular Diagnostics Cancer Market Size 2026-2031 ($ millions)
Figure 70. Japan Molecular Diagnostics Cancer Market Size 2026-2031 ($ millions)
Figure 71. Korea Molecular Diagnostics Cancer Market Size 2026-2031 ($ millions)
Figure 72. Southeast Asia Molecular Diagnostics Cancer Market Size 2026-2031 ($ millions)
Figure 73. India Molecular Diagnostics Cancer Market Size 2026-2031 ($ millions)
Figure 74. Australia Molecular Diagnostics Cancer Market Size 2026-2031 ($ millions)
Figure 75. Germany Molecular Diagnostics Cancer Market Size 2026-2031 ($ millions)
Figure 76. France Molecular Diagnostics Cancer Market Size 2026-2031 ($ millions)
Figure 77. UK Molecular Diagnostics Cancer Market Size 2026-2031 ($ millions)
Figure 78. Italy Molecular Diagnostics Cancer Market Size 2026-2031 ($ millions)
Figure 79. Russia Molecular Diagnostics Cancer Market Size 2026-2031 ($ millions)
Figure 80. Egypt Molecular Diagnostics Cancer Market Size 2026-2031 ($ millions)
Figure 81. South Africa Molecular Diagnostics Cancer Market Size 2026-2031 ($ millions)
Figure 82. Israel Molecular Diagnostics Cancer Market Size 2026-2031 ($ millions)
Figure 83. Turkey Molecular Diagnostics Cancer Market Size 2026-2031 ($ millions)
Figure 84. Global Molecular Diagnostics Cancer Market Size Market Share Forecast by Type (2026-2031)
Figure 85. Global Molecular Diagnostics Cancer Market Size Market Share Forecast by Application (2026-2031)
Figure 86. GCC Countries Molecular Diagnostics Cancer Market Size 2026-2031 ($ millions)
Figure 1. Molecular Diagnostics Cancer Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Molecular Diagnostics Cancer Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Molecular Diagnostics Cancer Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Molecular Diagnostics Cancer Sales Market Share by Country/Region (2024)
Figure 8. Molecular Diagnostics Cancer Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Molecular Diagnostics Cancer Market Size Market Share by Type in 2024
Figure 10. Molecular Diagnostics Cancer in Respiratory Cancer
Figure 11. Global Molecular Diagnostics Cancer Market: Respiratory Cancer (2020-2025) & ($ millions)
Figure 12. Molecular Diagnostics Cancer in Cancer of Digestive System
Figure 13. Global Molecular Diagnostics Cancer Market: Cancer of Digestive System (2020-2025) & ($ millions)
Figure 14. Molecular Diagnostics Cancer in Cancer of Urinary System
Figure 15. Global Molecular Diagnostics Cancer Market: Cancer of Urinary System (2020-2025) & ($ millions)
Figure 16. Molecular Diagnostics Cancer in Cancer of Circulatory System
Figure 17. Global Molecular Diagnostics Cancer Market: Cancer of Circulatory System (2020-2025) & ($ millions)
Figure 18. Molecular Diagnostics Cancer in Motor System Cancer
Figure 19. Global Molecular Diagnostics Cancer Market: Motor System Cancer (2020-2025) & ($ millions)
Figure 20. Molecular Diagnostics Cancer in Reproductive System Cancer
Figure 21. Global Molecular Diagnostics Cancer Market: Reproductive System Cancer (2020-2025) & ($ millions)
Figure 22. Molecular Diagnostics Cancer in Other
Figure 23. Global Molecular Diagnostics Cancer Market: Other (2020-2025) & ($ millions)
Figure 24. Global Molecular Diagnostics Cancer Market Size Market Share by Application in 2024
Figure 25. Global Molecular Diagnostics Cancer Revenue Market Share by Player in 2024
Figure 26. Global Molecular Diagnostics Cancer Market Size Market Share by Region (2020-2025)
Figure 27. Americas Molecular Diagnostics Cancer Market Size 2020-2025 ($ millions)
Figure 28. APAC Molecular Diagnostics Cancer Market Size 2020-2025 ($ millions)
Figure 29. Europe Molecular Diagnostics Cancer Market Size 2020-2025 ($ millions)
Figure 30. Middle East & Africa Molecular Diagnostics Cancer Market Size 2020-2025 ($ millions)
Figure 31. Americas Molecular Diagnostics Cancer Value Market Share by Country in 2024
Figure 32. United States Molecular Diagnostics Cancer Market Size Growth 2020-2025 ($ millions)
Figure 33. Canada Molecular Diagnostics Cancer Market Size Growth 2020-2025 ($ millions)
Figure 34. Mexico Molecular Diagnostics Cancer Market Size Growth 2020-2025 ($ millions)
Figure 35. Brazil Molecular Diagnostics Cancer Market Size Growth 2020-2025 ($ millions)
Figure 36. APAC Molecular Diagnostics Cancer Market Size Market Share by Region in 2024
Figure 37. APAC Molecular Diagnostics Cancer Market Size Market Share by Type (2020-2025)
Figure 38. APAC Molecular Diagnostics Cancer Market Size Market Share by Application (2020-2025)
Figure 39. China Molecular Diagnostics Cancer Market Size Growth 2020-2025 ($ millions)
Figure 40. Japan Molecular Diagnostics Cancer Market Size Growth 2020-2025 ($ millions)
Figure 41. South Korea Molecular Diagnostics Cancer Market Size Growth 2020-2025 ($ millions)
Figure 42. Southeast Asia Molecular Diagnostics Cancer Market Size Growth 2020-2025 ($ millions)
Figure 43. India Molecular Diagnostics Cancer Market Size Growth 2020-2025 ($ millions)
Figure 44. Australia Molecular Diagnostics Cancer Market Size Growth 2020-2025 ($ millions)
Figure 45. Europe Molecular Diagnostics Cancer Market Size Market Share by Country in 2024
Figure 46. Europe Molecular Diagnostics Cancer Market Size Market Share by Type (2020-2025)
Figure 47. Europe Molecular Diagnostics Cancer Market Size Market Share by Application (2020-2025)
Figure 48. Germany Molecular Diagnostics Cancer Market Size Growth 2020-2025 ($ millions)
Figure 49. France Molecular Diagnostics Cancer Market Size Growth 2020-2025 ($ millions)
Figure 50. UK Molecular Diagnostics Cancer Market Size Growth 2020-2025 ($ millions)
Figure 51. Italy Molecular Diagnostics Cancer Market Size Growth 2020-2025 ($ millions)
Figure 52. Russia Molecular Diagnostics Cancer Market Size Growth 2020-2025 ($ millions)
Figure 53. Middle East & Africa Molecular Diagnostics Cancer Market Size Market Share by Region (2020-2025)
Figure 54. Middle East & Africa Molecular Diagnostics Cancer Market Size Market Share by Type (2020-2025)
Figure 55. Middle East & Africa Molecular Diagnostics Cancer Market Size Market Share by Application (2020-2025)
Figure 56. Egypt Molecular Diagnostics Cancer Market Size Growth 2020-2025 ($ millions)
Figure 57. South Africa Molecular Diagnostics Cancer Market Size Growth 2020-2025 ($ millions)
Figure 58. Israel Molecular Diagnostics Cancer Market Size Growth 2020-2025 ($ millions)
Figure 59. Turkey Molecular Diagnostics Cancer Market Size Growth 2020-2025 ($ millions)
Figure 60. GCC Countries Molecular Diagnostics Cancer Market Size Growth 2020-2025 ($ millions)
Figure 61. Americas Molecular Diagnostics Cancer Market Size 2026-2031 ($ millions)
Figure 62. APAC Molecular Diagnostics Cancer Market Size 2026-2031 ($ millions)
Figure 63. Europe Molecular Diagnostics Cancer Market Size 2026-2031 ($ millions)
Figure 64. Middle East & Africa Molecular Diagnostics Cancer Market Size 2026-2031 ($ millions)
Figure 65. United States Molecular Diagnostics Cancer Market Size 2026-2031 ($ millions)
Figure 66. Canada Molecular Diagnostics Cancer Market Size 2026-2031 ($ millions)
Figure 67. Mexico Molecular Diagnostics Cancer Market Size 2026-2031 ($ millions)
Figure 68. Brazil Molecular Diagnostics Cancer Market Size 2026-2031 ($ millions)
Figure 69. China Molecular Diagnostics Cancer Market Size 2026-2031 ($ millions)
Figure 70. Japan Molecular Diagnostics Cancer Market Size 2026-2031 ($ millions)
Figure 71. Korea Molecular Diagnostics Cancer Market Size 2026-2031 ($ millions)
Figure 72. Southeast Asia Molecular Diagnostics Cancer Market Size 2026-2031 ($ millions)
Figure 73. India Molecular Diagnostics Cancer Market Size 2026-2031 ($ millions)
Figure 74. Australia Molecular Diagnostics Cancer Market Size 2026-2031 ($ millions)
Figure 75. Germany Molecular Diagnostics Cancer Market Size 2026-2031 ($ millions)
Figure 76. France Molecular Diagnostics Cancer Market Size 2026-2031 ($ millions)
Figure 77. UK Molecular Diagnostics Cancer Market Size 2026-2031 ($ millions)
Figure 78. Italy Molecular Diagnostics Cancer Market Size 2026-2031 ($ millions)
Figure 79. Russia Molecular Diagnostics Cancer Market Size 2026-2031 ($ millions)
Figure 80. Egypt Molecular Diagnostics Cancer Market Size 2026-2031 ($ millions)
Figure 81. South Africa Molecular Diagnostics Cancer Market Size 2026-2031 ($ millions)
Figure 82. Israel Molecular Diagnostics Cancer Market Size 2026-2031 ($ millions)
Figure 83. Turkey Molecular Diagnostics Cancer Market Size 2026-2031 ($ millions)
Figure 84. Global Molecular Diagnostics Cancer Market Size Market Share Forecast by Type (2026-2031)
Figure 85. Global Molecular Diagnostics Cancer Market Size Market Share Forecast by Application (2026-2031)
Figure 86. GCC Countries Molecular Diagnostics Cancer Market Size 2026-2031 ($ millions)
More Publications
Global Spinal Fusion Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
December 2024
104 pages
Global Kidney Cancer and Renal Cell Carcinoma (RCC) Drugs Market Growth (Status and Outlook) 2024-2030
US$ 3,660.00
March 2024
88 pages
Global Syndromic Multiplex Diagnostic Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
September 2025
114 pages
